SONOMABIO
Live / Registered — Registered (as of 08 Jul 2025)
What this means for you
Registered since 08 Jul 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97503974
- Registration number
- 7859998
- Mark type
- Stylized text
- Filed
- 14 Jul 2022
- Published for opposition
- 06 Jun 2023
- Registered
- 08 Jul 2025
- Attorney of record
- Thad Chaloemtiarana
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, cell therapy to treat diseases associated with inflammation such as autoimmune and neurodegenerative diseases, and biologic medications that reduce effector cells involved in diseases associated with inflammation, particularly, autoimmune and neurodegenerative diseases
Owner
- Sonoma Biotherapeutics, Inc., South San Francisco, CA, US
- Sonoma Biotherapeutics, Inc., South San Francisco, CA, US
- Sonoma Biotherapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 08 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Jun 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Jun 2025 — ASSIGNED TO LIE
- 09 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Jun 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Jun 2025 — NON-FINAL ACTION E-MAILED
- 09 Jun 2025 — SU - NON-FINAL ACTION - WRITTEN
- 29 May 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Mar 2025 — USE AMENDMENT FILED
- 29 May 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Mar 2025 — TEAS STATEMENT OF USE RECEIVED